SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 2,522.63 |
| Enterprise Value ($M) | 2,080.30 |
| Book Value ($M) | 660.94 |
| Book Value / Share | 5.54 |
| Price / Book | 3.82 |
| NCAV ($M) | 427.93 |
| NCAV / Share | 3.59 |
| Price / NCAV | 5.89 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.21 |
| Return on Assets (ROA) | 0.35 |
| Return on Equity (ROE) | 0.41 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.92 |
| Current Ratio | 5.11 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 539.00 |
| Assets | 772.01 |
| Liabilities | 111.07 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Flynn James E | 5.22 | -29.92 | |
| 13G/A | BlackRock, Inc. | 16.00 | 0.00 | |
| 13G/A | State Street Corp | 4.80 | -16.24 | |
| 13G/A | Vanguard Group Inc | 6.68 | 5.20 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 179,690 | 619,644 | 29.00 | |
| 186,624 | 772,321 | 24.16 | |
| 108,858 | 703,036 | 15.48 | |
| 120,124 | 672,543 | 17.86 | |
(click for more detail) |
|||